RTI Surgical Holdings, Inc, a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.
Read More…
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Phone386-418-8888
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$280.86 million
Profitability
Miscellaneous
Employees891
Next Earnings Date2/27/2020 (Estimated)
OptionableOptionable
RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions
What is RTI Surgical's stock symbol?
RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX."
How were RTI Surgical's earnings last quarter?
RTI Surgical Holdings Inc (NASDAQ:RTIX) posted its quarterly earnings results on Thursday, October, 31st. The medical equipment provider reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The medical equipment provider earned $76.13 million during the quarter. RTI Surgical had a negative net margin of 3.72% and a positive return on equity of 1.75%. View RTI Surgical's Earnings History.
When is RTI Surgical's next earnings date?
What price target have analysts set for RTIX?
3 equities research analysts have issued twelve-month price targets for RTI Surgical's shares. Their forecasts range from $5.00 to $8.00. On average, they expect RTI Surgical's share price to reach $6.67 in the next year. This suggests a possible upside of 235.0% from the stock's current price. View Analyst Price Targets for RTI Surgical.
What is the consensus analysts' recommendation for RTI Surgical?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RTI Surgical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for RTI Surgical.
Has RTI Surgical been receiving favorable news coverage?
Media coverage about RTIX stock has been trending very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. RTI Surgical earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for RTI Surgical.
Who are some of RTI Surgical's key competitors?
Some companies that are related to RTI Surgical include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Anika Therapeutics (ANIK), Antares Pharma (ATRS), Cerus (CERS) and OraSure Technologies (OSUR).
What other stocks do shareholders of RTI Surgical own?
Who are RTI Surgical's key executives?
RTI Surgical's management team includes the folowing people:
- Mr. Camille I. Farhat, CEO, Pres & Director (Age 49)
- Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 55)
- Mr. John N. Varela, Exec. VP of Global Operations (Age 52)
- Mr. Tony Lemus, VP of Global R&D, Clinical and Regulatory
- Ms. Molly Poarch, Director of Corp. Communications
Who are RTI Surgical's major shareholders?
RTI Surgical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Foundry Partners LLC (0.59%), Mackay Shields LLC (0.18%), Dupont Capital Management Corp (0.17%), Rhumbline Advisers (0.12%), California Public Employees Retirement System (0.10%) and Russell Investments Group Ltd. (0.01%). Company insiders that own RTI Surgical stock include Camille Farhat and Jonathon M Singer. View Institutional Ownership Trends for RTI Surgical.
Which major investors are selling RTI Surgical stock?
RTIX stock was sold by a variety of institutional investors in the last quarter, including Mackay Shields LLC, Foundry Partners LLC, Russell Investments Group Ltd. and California Public Employees Retirement System. View Insider Buying and Selling for RTI Surgical.
Which major investors are buying RTI Surgical stock?
RTIX stock was acquired by a variety of institutional investors in the last quarter, including Rhumbline Advisers and Dupont Capital Management Corp. Company insiders that have bought RTI Surgical stock in the last two years include Camille Farhat and Jonathon M Singer. View Insider Buying and Selling for RTI Surgical.
How do I buy shares of RTI Surgical?
Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is RTI Surgical's stock price today?
One share of RTIX stock can currently be purchased for approximately $1.99.
How big of a company is RTI Surgical?
RTI Surgical has a market capitalization of $146.90 million and generates $280.86 million in revenue each year. The medical equipment provider earns $-1,250,000.00 in net income (profit) each year or $0.12 on an earnings per share basis. RTI Surgical employs 891 workers across the globe.View Additional Information About RTI Surgical.
What is RTI Surgical's official website?
How can I contact RTI Surgical?
RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected]
MarketBeat Community Rating for RTI Surgical (NASDAQ RTIX)
MarketBeat's community ratings are surveys of what our community members think about RTI Surgical and other stocks. Vote "Outperform" if you believe RTIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RTIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
